Cargando…

Neuroprotective effect of sodium alginate against chromium-induced brain damage in rats

Oral exposure to chromium hexavalent [Cr(VI)] has disastrous impacts and affects many people worldwide. Cr(VI) triggers neurotoxicity via its high oxidation potential by generating high amount of ROS. Meanwhile, alginates are known by their chelating activity and ability to bind heavy metals and tox...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleh, Eman M., Hamdy, Germine M., Hassan, Rasha E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009676/
https://www.ncbi.nlm.nih.gov/pubmed/35421180
http://dx.doi.org/10.1371/journal.pone.0266898
_version_ 1784687322345766912
author Saleh, Eman M.
Hamdy, Germine M.
Hassan, Rasha E.
author_facet Saleh, Eman M.
Hamdy, Germine M.
Hassan, Rasha E.
author_sort Saleh, Eman M.
collection PubMed
description Oral exposure to chromium hexavalent [Cr(VI)] has disastrous impacts and affects many people worldwide. Cr(VI) triggers neurotoxicity via its high oxidation potential by generating high amount of ROS. Meanwhile, alginates are known by their chelating activity and ability to bind heavy metals and toxins, in addition to their antioxidant, anti-inflammatory, and anti-apoptotic activities. So, this study aimed to explore the neuroprotective potential of sodium alginate (SA) against cellular injury, DNA damage, macromolecule alterations, and apoptosis induced by oral ingestion of Cr. Forty Wistar male rats were divided into 4 groups; group I: standard control ingested with the vehicle solution, group II: Cr-intoxicated group received 10 mg/kg b.w. of potassium dichromate orally by gavage and kept without treatment, group III: SA group in which rats were orally exposed to 200 mg/kg b.w. of SA only, and group IV: SA-treated group that received 200 mg/kg b.w. of SA along with Cr for 28 consecutive days. Neurotransmitters such as Acetyl choline esterase (AchE), Monoamine oxidase A (MAOA) concentrations, Dopamine (DA) and 5-Hydroxytryptamine (5-HT) levels were assessed in brain homogenate tissues. Neurobiochemical markers; NAD(+) and S100B protein were investigated in the brain tissues and serum, respectively. Levels of HSP70, caspase-3, protein profiling were evaluated. DNA damage was determined using the Comet assay. Results revealed a significant reduction in the AchE and MAOA concentrations, DA, 5-HT, and NAD(+) levels, with an increase in the S100B protein levels. Cr(VI) altered protein pattern and caused DNA damage. High levels of HSP70 and caspase-3 proteins were observed. Fortunately, oral administration of SA prevented the accumulation of Cr in brain homogenates and significantly improved all investigated parameters. SA attenuated the ROS production and relieved the oxidative stress by its active constituents. SA can protect against cellular and DNA damage and limit apoptosis. SA could be a promising neuroprotective agent against Cr(VI)-inducing toxicity.
format Online
Article
Text
id pubmed-9009676
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-90096762022-04-15 Neuroprotective effect of sodium alginate against chromium-induced brain damage in rats Saleh, Eman M. Hamdy, Germine M. Hassan, Rasha E. PLoS One Research Article Oral exposure to chromium hexavalent [Cr(VI)] has disastrous impacts and affects many people worldwide. Cr(VI) triggers neurotoxicity via its high oxidation potential by generating high amount of ROS. Meanwhile, alginates are known by their chelating activity and ability to bind heavy metals and toxins, in addition to their antioxidant, anti-inflammatory, and anti-apoptotic activities. So, this study aimed to explore the neuroprotective potential of sodium alginate (SA) against cellular injury, DNA damage, macromolecule alterations, and apoptosis induced by oral ingestion of Cr. Forty Wistar male rats were divided into 4 groups; group I: standard control ingested with the vehicle solution, group II: Cr-intoxicated group received 10 mg/kg b.w. of potassium dichromate orally by gavage and kept without treatment, group III: SA group in which rats were orally exposed to 200 mg/kg b.w. of SA only, and group IV: SA-treated group that received 200 mg/kg b.w. of SA along with Cr for 28 consecutive days. Neurotransmitters such as Acetyl choline esterase (AchE), Monoamine oxidase A (MAOA) concentrations, Dopamine (DA) and 5-Hydroxytryptamine (5-HT) levels were assessed in brain homogenate tissues. Neurobiochemical markers; NAD(+) and S100B protein were investigated in the brain tissues and serum, respectively. Levels of HSP70, caspase-3, protein profiling were evaluated. DNA damage was determined using the Comet assay. Results revealed a significant reduction in the AchE and MAOA concentrations, DA, 5-HT, and NAD(+) levels, with an increase in the S100B protein levels. Cr(VI) altered protein pattern and caused DNA damage. High levels of HSP70 and caspase-3 proteins were observed. Fortunately, oral administration of SA prevented the accumulation of Cr in brain homogenates and significantly improved all investigated parameters. SA attenuated the ROS production and relieved the oxidative stress by its active constituents. SA can protect against cellular and DNA damage and limit apoptosis. SA could be a promising neuroprotective agent against Cr(VI)-inducing toxicity. Public Library of Science 2022-04-14 /pmc/articles/PMC9009676/ /pubmed/35421180 http://dx.doi.org/10.1371/journal.pone.0266898 Text en © 2022 Saleh et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Saleh, Eman M.
Hamdy, Germine M.
Hassan, Rasha E.
Neuroprotective effect of sodium alginate against chromium-induced brain damage in rats
title Neuroprotective effect of sodium alginate against chromium-induced brain damage in rats
title_full Neuroprotective effect of sodium alginate against chromium-induced brain damage in rats
title_fullStr Neuroprotective effect of sodium alginate against chromium-induced brain damage in rats
title_full_unstemmed Neuroprotective effect of sodium alginate against chromium-induced brain damage in rats
title_short Neuroprotective effect of sodium alginate against chromium-induced brain damage in rats
title_sort neuroprotective effect of sodium alginate against chromium-induced brain damage in rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009676/
https://www.ncbi.nlm.nih.gov/pubmed/35421180
http://dx.doi.org/10.1371/journal.pone.0266898
work_keys_str_mv AT salehemanm neuroprotectiveeffectofsodiumalginateagainstchromiuminducedbraindamageinrats
AT hamdygerminem neuroprotectiveeffectofsodiumalginateagainstchromiuminducedbraindamageinrats
AT hassanrashae neuroprotectiveeffectofsodiumalginateagainstchromiuminducedbraindamageinrats